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Abstract: In recent years, fungi have been recognized as producers of acetylcholinesterase (AChE)
inhibitors, agents important for the prevention of Alzheimer’s disease (AD). This study aimed to ex-
amine the AChE inhibitory, the antioxidative and antibacterial activity of two different Schizophyllum
commune strains that originated from Serbia (SRB) and Italy (IT). Submerged cultivation of grown
mycelia (M) and fermentation broth (F) of ethanol (EtOH) and polysaccharide (PSH) extracts lasted
for 7, 14, 21 and 28 days. For AChE activity Ellman method was performed, while for antioxida-
tive activity, sevendifferent assays were conducted: DPPH, ABTS, FRAP, SOA, OH, NO together
with total phenolic content. Antimicrobial screen, LC–MS/MS technique and FTIR measurements
were performed. Different isolates exhibited different AChE activity, with PSH being the strongest
(SRB, M, 28 days IC90 79.73 ± 26.34 µg/mL), while in EtOH extracts, IT stood out (F, 14 days, IC50
0.8 ± 0.6 µg/mL). PSH extracts (7 days) exhibit significant antioxidative activity (AO), opposite to
EtOH extracts where 14 and 21days periods stood out. Only tw extracts showed antibacterial activity.
Following LC–MS/MS analysis p-hydroxybenzoic and gallic acids were the most abundant phenolics.
PSH extracts demonstrated remarkable results, making this study debut and introducing S. commune
as a valuable resource of AChE inhibitors.
Keywords: Schizophyllum commune; submerged cultivation; acetylcholinesterase inhibition; antioxidant
1. Introduction
Reactive oxygen species (ROS) represent the most potent free radicals since they can
have a destructive effect on various cells and cause oxidative stress [1,2]. The imbalance
between the production and quenching of free radicals may lead to a wide range of diseases,
including neurodegenerative disorders such as Alzheimer’s (AD) [3]. Even though the
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exact cause of AD remains a question of debate, various studies suggest that oxidative
stress plays a key role in an early response [2–5]. Furthermore, due to a lack of treatment
to stop or reverse its progression, acetylcholinesterase inhibitors (AChI) have become an
attractive research topic. AChI medications can help with memory symptoms and other
cognitive changes by increasing the level of acetylcholine in the brain [6]. Hence, a wide
range of organisms have been studied in order to find a biologically active compound that
would be a successful AChI [7] and today, the only natural approved agents are alkaloids,
such as galantamine and huperzine A [8]. Nevertheless, problems with bioavailability and
numerous side effects pointed out that there is aneed for other AChI [7–9].
In recent years, mushrooms have been recognized as producers of non-alkaloid agents
that inhibit acetylcholinesterase enzyme (AChE) [10,11] as well as the organisms which
possess naturally occurring antioxidants [12]. Many structurally different polysaccharides
with high antitumor activity and no side effects have been isolated from fungi [13], and
it has been observed that they have the ability to improve memory and learning [14,15].
In addition, secondary metabolites, mostly phenolics, are considered to be responsible for
antioxidant activity (AO) [10,16]. Submerged cultivation represents a controlled biotech-
nological process for providing valuable mycelial biomass and extracellular medium,
which contain different organic compounds and may show different properties. More-
over, it can provide a faster route for antioxidant and exopolysaccharide production in
basidiomycetes [17].
Schizophyllum commune (phylum Basidiomycota, order Agaricales, family Schizophyllaceae)
is a widely distributed wood—decaying basidiomycete—that is present on all continents
except Antarctica, but it is more common to be found in warmer regions with high humid-
ity [18]. Thanks to the production of a neutral extracellular polysaccharide schizophyllan
(Sonifilan, SPG), a β-1,3 glucan with β-1,6 branching and molecular weight of 450 kDa, that
has shown significant antitumor, anticancer, immunomodulatory and anti-inflammatory
effects [12,19,20], other benefits of this mushroom are being investigated [15]. Considering
that environmental conditions in different geographical regions influence, to a great extent
on the bioactive properties, the purpose of this study was to examine and compare AChE
inhibitory and antioxidative activity, in vitro, of ethanol and polysaccharide extracts of two
different strains of S. commune originated from Serbia (SRB) and Italy (IT). Both isolates
were cultivated in submerged conditions in order to examine and compare the activity of
mycelium biomass (M) and fermentation broth (F).
2. Materials and Methods
2.1. Biological Material
Two dikaryon strains of the wild-growing S. commune Fries 1815. (Ph. Basidiomycota,
Cl. Agaricomycetes, O. Auriculariales, Fam. Schizopyllaceae) were collected near Bologna,
Italy, in 2016 and in Zmajevac (Fruška Gora mountain) in Serbia in 2012. Mushroom
identification was carried out by studying the fungal morphology macroscopically (color,
shape, size and hyphae) and microscopically [21]. Mycelia wereisolated from the fruiting
bodies of both isolates and cultivated at 26 ◦C, for 10 days, on malt agar (Torlak, Serbia).
Mycelia of both isolates were deposited in fungal culture collection FUNGICULT, (https:
//www.pmf.uns.ac.rs/en/research/groups/profungi/), of the ProFungi laboratory at
Department of Biology and Ecology-DBE, Faculty of Natural Sciences-PMF, University of
Novi Sad-UNS. The isolates were referenced under the following numbers: 0043 and 0047,
respectively, for S. commune SRB and IT.
2.2. Submerged Cultivation and Preparation of Extracts
Mycelia of SRB and IT strain from culture collection were cultivated on malt agar
(Torlak, Serbia) at 26 ◦C for 12 days in a thermal incubator in the dark, each isolate in tripli-
cate. A sterilized fermentation medium was prepared in Erlenmeyer flasks (500 mL nar-
row throat flasks), in which 5 plaques of pure culture mycelia, approx. 1 cm2 in size,
were transferred into100 mL of fermentation broth that contained 0.5 g peptone, 3.7g
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glucose, 0.17 g maltose, 0.17 g fructose, 0.17 g xylose, 0.5 g yeast extract, 0.1 g K2HPO4,
0.05 g MgSO4x7H2Oand 0.005 g vitamin B1. Incubation on a rotary shakerat 120 rpm,
26 ◦C and in the light (IKA KS 4000i control, Werke GmbH and Co.KG, Staufen, Germany)
lasted for 7, 14, 21 and 28 days. Every 7 days, three replicates of SRB and IT isolates
were filtered (diaphragm vacuum pump GM-0.5, HINOTEK Group Limited, China) and
lyophilized at −80 ◦C under vacuum (Bio alpha, Martin Christ GmbH, Switzerland), F
for 72h and M for 48h. Afterward, samples were grounded to a fine powder (IKA A11
basic, Germany) and kept in dark bottles at room temperature until further use. Based
on the measured masses of mycelium and lyophilized filtrate, appropriate growth curves
were made (Figures S1 and S2). The mass of each strain was derived from 1200 mL of
fermentation medium (three replicates with 100 mL for each incubation time). Ethanol
extracts (EtOH), M and F, were prepared by mixing 5 g of fungal material with 100 mL of
96% ethanol-EtOH (Zorka Pharma, Serbia) and stirring at 120 rpm at room temperature
for 72 h. Afterward, extracts were evaporated (Buchi R-210, Switzerland) until the dry
weight (d.w.) is reached and redissolved in 80% EtOH to achieve a concentration of 10
and 20% (w/v). Polysaccharide (PSH) extracts were prepared according to Ren et al. with
some modifications [22]. The modifications refer to the centrifugation speed;more precisely,
instead of 14,000 rpm, 12,000 rpm was performed.
2.3. Determination of AChE Activity
In vitrodetermination of AChE inhibitory activity of PSH and EtOH extracts was done
according to Ellman et al. adapted for the use in 96-well microplates [23]. As an artificial
substrate, acetylcholine iodide-AChI, originating from electric eel (Sigma-Aldrich, Chemie
GmbH—Schnelldorf, Germany), was used for degradation of the AChE enzyme (Sigma-
Aldrich, Merck Group, Germany). The reaction mixture contained 20 µL of the fungal
extract, 150 µL of reagent A (Ellman’s reagent and AChI) and 50 µL of reagent B (AChE
enzyme at 518 U/mL previously dissolved in phosphate buffer, pH 8.0), while donepezil
at 1 mg/mL (Donecept, Zdravlje, Leskovac, Serbia) was used as a positive control. The
absorbance was measured at λ = 412 nm on a 96-well plate reader (Multiskan Ascent,
Thermo Electron Corporation, USA) in a total of 15 measurements with an interval of 1 min.
The concentration range of analyzed extracts was from 10% to 0.01%. The percentage (%)
of enzyme inhibition was calculated based on the following Equation (1):
IAChE (%) = (1 − Asample/Acontrol) × 100% (1)
where Asample and Acontrol stand for the absorbance of the tested and control samples,
respectively. All measurements were performed in triplicate, and the results were presented
as IC50 and IC90 values, with lower values corresponding to higher AChE activity of the
sample. The reference inhibition time is a period of 10 min or 600 s, respectively.
2.4. Determination of Antioxidant Activity
For the in vitro evaluation of the AO of PSH and EtOH extracts, the scavenging
effect on 2,2′-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azinobis(3-ethylbenzthiazolin)6-
sulfonic acid (ABTS) radicals, in addition to ferric reducing antioxidant power assay (FRAP
assay) of extracts was determined. Additionally, the capability to neutralize superoxide
anion (SOA, O2−), hydroxyl (OH·) and nitric oxide radical (NO·) was assessed for EtOH.
Synthetic antioxidant propyl gallate (PG) was used as a positive control for RSC assays,
and all assays were completed in triplicates. The results were presented as the mean values
± standard deviations (SD).2.4.1. DPPH Assay
The DPPH free radical scavenging assay was carried out according to the previously
described procedure [24]. Briefly, the reaction mixture contained 60 µL of 90 µM DPPH
reagent, 180 µL MeOH and 10 µL of the relevant S. commune extract (EtOH and PSH). The
mixture was kept in the dark at room temperature for 30 min, and the absorbance was
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measured at λ = 515 nm (multiscan, Thermo Scientific, Waltham, MA, USA). The following
Equation (2) was used for the calculation of radical scavenging capacity (RSC):
RSC (DPPH) (%) = (1 − Asample/Acontrol) × 100% (2)
where Asample and Acontrol stand for the absorbance of the tested extracts and control. After
regression analysis, results were presented as IC50 values (µg/mL) (the concentration of
the test substance at which 50% of the radicals is neutralized).
2.4.1. ABTS Assay
The ABTS test, based on spectrophotometric monitoring of the transformation of the
blue-green colored cation radical ABTS+ into its neutral, colorless form, was carried out
according to Arnao et al. [25]. ABTS+ was produced directly by reacting 7 mM ABTS
solution with 2.45 mM K2S2O8, and after incubation (12–16 h in the dark at the room
temperature) on the day of the assay, ABTS solution was diluted with EtOH to achieve
absorbance between 0.800and 0.900 at λ =734 nm. 10µL of fungal extract (EtOH and PSH)
was added to 290 µL of ABTS solution and mixed. The sample absorbance was read at
λ = 734 nm after a 5-min incubation at room temperature, while Trolox was used to calculate
the standard curve. The ABTS radical scavenging activity was expressed as mg of Trolox
equivalents per g dry weight (mg TE/g d.w.).
2.4.2. FRAP Assay
FRAP assay was done by the method of Benzie and Strain [26]. The fresh FRAP
reagent consists of 10 mmol/LTPTZ solution in 40 mmol/L HCl, 0.02 mmol/L FeCl3x6H2O
and acetate buffer (pH 3.6) in ratio 10:1:1. For the assay, 10 µL of each extract was mixed
with 225 µL of FRAP reagent and 22.5 µL of dH2O. The absorbance was measured after
6 min at 593, while ascorbic acid (AA) was used to calculate the standard curve. Reducing
power of analyzed fungal extracts (EtOH and PSH) was expressed mg AA equivalents per
g dry weight (mg AAE/g d.w.).
2.4.3. Superoxide Anion Radical Scavenging (SOA) Assay
The antiradical O2− the activity of tested EtOH extracts was evaluated by a previously
described method [27], based on measuring extract the ability to neutralize these radicals
formed during aerobic reduction of NBT by NADH in the presence of phenazine methyl
sulfate. The standard antioxidant PG was used as a positive control, and the neutralization
potential of RSCO2-was calculated according to the formula in Section 2.4.1. The results
were expressed as the mean of the three IC50 values obtained ± SD (µg/mL).
2.4.4. OH Assay
RSC activity of OH· was determined by the modified method of Halliwell and Gut-
teridge [28]. 100 µL H2O2, 100 µL FeSO4 and 100 µL 2-deoxyribose-D-ribose were mixed
with different concentration of EtOH fungal extract (10 µL) and 2.7 mL of phosphate buffer
(pH 7.4). Samples were incubated for 60 min at 37 ◦C, and 200 µL of EDTA (ethylenedi-
aminetetraacetic acid) and 2 mL of TBA reagent (5.2 mL perchloric acid, 1.5 g thiobarbituric
acid and 60g trichloroacetic acid diluted in 400 mL dH2O) were added in a mixture. The
absorbance of the reaction mixture (pink complex) was noted at λ = 532 nm, and results
were expressed as IC25 values ± SD (µg/mL).
2.4.5. NO Assay
The concentration of nitrite ions was determined according to Green et al. [29]. The
reaction mixture contained 15 µL of extract, 250 µL 10 mmol/L sodium nitroprusside and
250 µL phosphate buffer (pH 7.4). After incubation (90 min at room temperature and
constant light), 500 µL of Griess reagent (a mixture of 0.2% solution of N-(1-naphthyl)-
ethylenediamine dihydrochloride and 2% solution of sulfanilamide in 4% phosphoric acid)
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was added. The absorbance was measured at λ = 546 nm, and RSC was expressed as
IC25 ± SD (µg/mL).
2.5. Antibacterial Activity
In vitroantibacterial susceptibility, assays were performed using 2 Gram-positive
(Staphylococcusaureus and Bacillus cereus) and Gram-negative (Escherichia coli and
Pseudomonasaeruginosa) bacteria strains from American Type Culture Collection (ATCC).
Antimicrobial screen included agar-well diffusion and disc-diffusion assays in the eval-
uation of the antibacterial activity of EtOH fungal extracts of stock concentration, 10%
(w/v). Evaluation of activity was performed according to the CLSI procedure [30] and the
previously described method [16]. Evaluation of minimal inhibitory concentration (MIC)
and minimal bactericidal concentration (MBC) was performed by the two-fold dilution
susceptibility method according to the CLSI procedure [31] and Karaman et al. [32]. All
tests were carried out in triplicate.
2.6. Determination of Total Phenolic Content
Determination of the total phenolic content (TP) was performed by the method of
Singleton et al. [33]. Extracts were examined in the concentration of 0.625 to 50 mg/mL,
while gallic acid (standard compound) was prepared in ten concentrations ranging from
0 to 100 µg/mL 25 µL of each extract or standard solution, except in blank probe where
only the solvent was used (80% EtOH), was added to 125 µL of 0.1 mol/L Folin–Ciocâlteu
reagent (FC) and mixed with 100 µL of sodium carbonate (7.5%) after 10 min. Absorbance at
λ = 760 nm was read after 2 h incubation time. The phenolics concentration was determined
by comparison with the standard calibration curve of gallic acid, and results were presented
as a mean value of triplicated ± SD. The total phenol value was expressed as mg of gallic
acid equivalents (GAE) per g of dry weight.
2.7. Fourier Transform Infrared Spectroscopy Analysis (FTIR)
FTIR spectra of the EtOH and PSH spectra were recorded on a Thermo-Nicolet Model
6700 spectrophotometer (Thermo Scientific, USA) equipped with Smart Orbit (Diamond)
ATR accessory and OMNIC 7.3 software. Spectra were recorded in the 400–4000 cm−1 wave
number range.
2.8. Hydrolysis
For analysis of the monosaccharide composition of PSH extracts, paper chromatogra-
phy was applied. Each lyophilized PSH extract (2 mg) was hydrolyzed with 2 M TFA (2 mL)
in a sealed tube at 100 ◦C overnight. Samples were concentrated by evaporation under
reduced pressure (below 50 ◦C) to dryness. Residual TFA was removed by two evaporation
cycles with 0.5 mL of isopropanol, and the final residue was dissolved in 0.02 mL ofdistilled
water and analyzed by PC on Whatman No.1 chromatography paper (descending method)
in the solvent system ethyl-acetate:pyridine:water (10:4:3 v/v/v). Components were visual-
ized with alkaline silver nitrate [34]. D-Galactose, D-glucose, D-mannose, D-xylose, and
D-ribose were used as standards.
2.9. LC–MS/MS Analysis
The quantification of the selected phenolic compounds in PSH and EtOH extracts
of S. commune isolates was carried out using the slightly modified LC–MS/MS method
by Orčić et al. [35]. To obtain the high selectivity and sensitivity, the selected reactions
monitoring (SRM) acquisition mode was used since only ions specific to the targeted
analytes were monitored. Extracts and standards were analyzed using Agilent Technologies
1200 Series high-performance liquid chromatography coupled with Agilent Technologies
6410A Triple Quad tandem mass spectrometer with electrospray ion source and controlled
by Agilent Technologies MassHunter Workstation software Data Acquisition (ver. B.03.01).
Compounds were separated on Zorbax Eclipse XDB-C18 (50 mm × 4.6 mm, 1.8 m) rapid
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resolution column held at 50 ◦C. Mobile phase was delivered at flow rate of 0.5 mL/min
(instead of 1 mL/min) in gradient mode (0 min 30% B, 12 min 70% B, 18 min 100% B, 24 min
100% B, re-equilibration time 6 min, instead of 0 min 30% B, 6 min 70% B, 9 min 100% B,
12 min 100% B, re-equilibration time 3 min). Eluted compounds were detected by MS, using
the ion source parameters as follows: nebulization gas (N2) pressure 40 psi, drying gas
(N2) flow 9 L/min and temperature 350 ◦C, capillary voltage 4 kV, negative polarity. Data
were acquired in dynamic MRM mode, using the optimized compound-specific parameters
(retention time, precursor ion, product ion, fragmentor voltage, collision voltage). For all the
compounds, peak areas were determined using Agilent MassHunter Workstation software
Qualitative Analysis (ver. B.03.01). Calibration curves were plotted, and concentrations of
samples calculated using the OriginLabs Origin Pro (ver. 9.0) software.
2.10. Statistical Analysis
All assays were performed in triplicate. The results were expressed as mean ± SD.
IC50 and IC25 values were determined by the linear regression analysis of RSC (Origin Pro
2016 software, version 9.3). The data that have a normal distribution were subjected to
two-way analysis of variance (ANOVA)and multivariate analysis of variance (MANOVA).
Tukey’s test was used to determine significant differences (p < 0.05) between the extracts.
Nonparametric Friedman tests and posthoc LSD tests were used for data that do not have a
normal distribution. The correlation between antioxidant capacity and total phenols content
was established using the Pearson’s product-moment correlation (normally distributed
data) and Spearman correlation (data that do not have a normal distribution). The statistical
analysis was performed using the IBM SPSS Statistics software version 22.0 for Windows.
3. Results
3.1. Inhibition of AChEEnzyme
The strongest potency was observed for PSH extracts of S. commune, where the highest
concentration range (1%) overtakes IC90 (Figure 1A). Results of AChE inhibition activity
(AChEI) of EtOH extracts were presented as IC50 value, owing to the lower inhibition than

























Extracts  DPPH 1 (IC50) (μg/mL)  ABTS 2(mg TE/g d.w.)  FRAP 3(mg AAE/g d.w.) 
S. commune IT  PSH  EtOH  PSH  EtOH  PSH  EtOH 
F 
7 days  16.03 ± 4.30 a  72.65 ± 9.15 a  6.64 ± 0.66 a  5.17 ± 0.03 a  65.11 ± 6.27 a  42.58 ± 3.47 a 
14 days  107.94 ± 2.36 a  63.67 ± 2.65 a  8.20 ± 0.94 a  4.95 ± 0.41 a  66.73 ± 12.11 a  99.00 ± 2.73 a 
21 days  74.76 ± 19.70 a  55.43 ± 1.89 a  5.69 ± 0.52 a  5.27 ± 0.22 a  82.96 ± 0.94 a  91.65 ± 0.96 a 
28 days  189.81 ± 7.96 a  69.15 ± 3.98 a  2.86 ± 1.30 a  3.38 ± 0.06 a  28.44 ± 7.72 a  47.82 ± 5.28 a 
M 
7 days  94.89 ± 8.41 a  82.69 ± 1.93 a  5.16 ± 1.63 a  5.29 ± 0.05 a  40.03 ± 3.41 a  66.39 ± 3.84 a 
14 days  14.45 ± 6.83 a  49.34 ± 0.65 a  1.63 ± 1.71 a  5.20 ± 0.08 a  6.49 ± 7.40 a  81.30 ± 1.98 a 
21 days  85.39 ± 1.61 a  120.63 ± 3.29 a  7.49 ± 0.67 a  5.84 ± 0.06 a  79.12 ± 10.77 a  14.22 ± 1.32 a 
28 days  93.48 ± 0.01 a  105.39 ± 1.66 a  5.12 ± 0.39 a  4.85 ± 0.19 a  33.67 ± 5.35 a  32.46 ± 1.27 a 
S. commune SRB 
F 
7 days  15.76 ± 0.63 a  70.86 ± 2.52 b  2.60 ± 0.14 a  3.80 ± 0.08 a  0.28 ± 0.09 b  61.81 ± 4.78 a,c 
14 days  32.42 ± 3.09 a  53.61 ± 2.32 b  7.40 ± 0.19 a  3.26 ± 0.96 a  9.69 ± 3.67 b  107.86 ± 12.8 a,c 
21 days  30.18 ± 2.25 a  55.96 ± 1.31 b  7.62 ± 0.62 a  4.65 ± 0.31 a  57.10 ± 2.35 b  89.97 ± 12.81 a,c 
28 days  69.69 ± 3.93 a  67.31 ± 1.03 b  3.25 ± 1.98 a  3.40 ± 0.09 a  4.36 ± 1.36 b  80.28 ± 3.21 a,c 
M 
7 days  18.92 ± 6.12 a  377.71 ± 14.85 b  7.78 ± 0.41 a  6.01 ± 0.07 a  20.89 ± 1.67 b  11.44 ± 0.84 a,d 
14 days  71.55 ± 3.43 a  74.65 ± 1.74 b  3.17 ± 0.44 a  3.02 ± 0.10 a  9.55 ± 0.51 b  5.99 ± 0.20 a,d 
21 days  69.13 ± 4.24 a  164.28 ± 2.52 b  2.30 ± 0.31 a  5.43 ± 0.53 a  5.61 ± 1.83 b  10.77 ± 1.05 a,d 
Figure 1. Comparative pre-presentation of acetylcholinesterase (AChE) inhibitory activity of two different isolates (Italy
(IIT) and Serbia (SRB)) of S. commune:(A) inhibitory activity of submerged polysaccharide (PSH) extracts presented as IC90
values (µg/mL); (B) inhibitory activity of EtOH extracts presented as IC50 values (µg/mL).
Different strains of S. commune (IT, SRB) showed different AChEI activity. The PSH
extracts of the SRB strain showed higher activity compared to the IT strain, while in
EtOH extracts, the opposite was obtained (Figure 1). Among PSH extracts, the highest
activity exhibited M of SRB strain af er 28 days of incubation (IC90 79.73 ± 26.34 µg/mL),
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while among EtOH, the strongest extract was F of IT strain after 14 days of incubation
(IC50 0.8 ± 0.6 µg/mL).
By comparing the inhibitory activity of M and F, higher AChEI activity was observed
in the F within EtOH extract, while in PSH extracts M was stronger. Among EtOH extracts,
differences in activity were related to the incubation period, and the strongest activity
was shown after 14 days of incubation, apart from F extract originating from SRB, which
showed the strongest activity after 28 days of incubation. PSH extracts did not show
a statistically significant difference (ANOVA, p < 0.05) in inhibition of AChE when it comes
to the incubation period, as opposed to EtOH extracts.
3.2. Determination of Antioxidant Activity
3.2.1. DPPH Assay
All tested samples exhibited antiradical activity, with PSH being more active (Table 1).
Among PSH extracts, the highest ability to capture DPPH radicals was shown by M after
14 days (IC50 14.45 ± 6.83 for IT) and 7 days of cultivation (IC50 18.92 ± 6.12 for SRB),
while within F extracts those incubated 7 days distinguished (IC50 16.03 ± 4.30 µg/mL for
IT isolate and IC5015.76 ± 0.63 µg/mL for SRB isolate, respectively).
For EtOH extracts, the AO of F increased linearly from the 7th to the 21st day
when it reached its highest activity (IC50 55.43 ± 1.89 µg/mL for IT isolate and IC50
55.96 ± 1.31 µg/mL for SRB isolate, respectively), and then on the 28th day, it began to de-
cline for both isolates. Among M extracts, the analyzed antiradical activity had variations,
but nevertheless, on day 14, they proved to havethe best ability to neutralize free radicals
(IC50 49.34 ± 0.65 µg/mL for IT and IC50 74.65 ± 1.74 µg/mL for SRB, respectively).
3.2.2. ABTS Assay
All analyzed samples (PSH and EtOH) showed the ability to “capture” ABTS radicals,
with the PSH extracts being more active (Table 1). When we compare the two strains,
F extracts were stronger in IT isolate and M extracts in SRB isolate. Overall, M extracts
exhibited stronger activity compared to the F in both isolates.
3.2.3. FRAP Assay
The ferric reducing ability of PSH and EtOH extract for both isolates was evaluated
and compared (Table 1). By comparing all extracts, IT strain was more effective, with
the exception of one SRB F extract (EtOH, 14 days), which exhibited the greatest activity
(107.86 ± 12.81 mg AAE/g d.w). In all samples, F extracts showed a higher FRAP value
than M. Moreover, in both strains, PSH F extracts demonstrated lower activity than EtOH
F, as opposed to M extracts, where PSH extracts were stronger. According to statistical
analysis (ANOVA, p < 0.05) incubation period did not increase the reduction potential of
the extracts.
3.2.4. SOA Assay
All tested EtOH extracts showed the ability to neutralize O2−. SRB strain was more
potent compared to IT, while F extracts of both strains showed much higher antiradical
activity (Table 2).
3.2.5. OH Assay
EtOH extracts of S. commune (IT and SRB) showed the best OH• neutralizing activity
after 28 days of incubation (IC25 10.80 ± 0.54 µg/mL for F IT, IC25 89.69 ± 0.38 µg/mL
for F SRB and IC25 85.57 ± 0.12 µg/mL for M SRB), apart from M extract of IT strain
which displayed the highest activity after 7 days (IC25 20.20 ± 1.36 µg/mL) (Table 2).
Summarized, extracts from IT strain were more effective.
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Table 1. Comparative review of the antioxidant activity (AO) of submerged polysaccharide (PSH) and ethanol (EtOH) extracts of S. commune—28days—incubation time; DPPH—DPPH
assay; ABTS—ABTS assay; TE—Trolox equivalents; FRAP—FRAP assay; AAE—ascorbic acid equivalents.
Extracts DPPH 1 (IC50) (µg/mL) ABTS 2(mg TE/g d.w.) FRAP 3(mg AAE/g d.w.)
S. commune IT PSH EtOH PSH EtOH PSH EtOH
F
7 days 16.03 ± 4.30 a 72.65 ± 9.15 a 6.64 ± 0.66 a 5.17 ± 0.03 a 65.11 ± 6.27 a 42.58 ± 3.47 a
14 days 107.94 ± 2.36 a 63.67 ± 2.65 a 8.20 ± 0.94 a 4.95 ± 0.41 a 66.73 ± 12.11 a 99.00 ± 2.73 a
21 days 74.76 ± 19.70 a 55.43 ± 1.89 a 5.69 ± 0.52 a 5.27 ± 0.22 a 82.96 ± 0.94 a 91.65 ± 0.96 a
28 days 189.81 ± 7.96 a 69.15 ± 3.98 a 2.86 ± 1.30 a 3.38 ± 0.06 a 28.44 ± 7.72 a 47.82 ± 5.28 a
M
7 days 94.89 ± 8.41 a 82.69 ± 1.93 a 5.16 ± 1.63 a 5.29 ± 0.05 a 40.03 ± 3.41 a 66.39 ± 3.84 a
14 days 14.45 ± 6.83 a 49.34 ± 0.65 a 1.63 ± 1.71 a 5.20 ± 0.08 a 6.49 ± 7.40 a 81.30 ± 1.98 a
21 days 85.39 ± 1.61 a 120.63 ± 3.29 a 7.49 ± 0.67 a 5.84 ± 0.06 a 79.12 ± 10.77 a 14.22 ± 1.32 a
28 days 93.48 ± 0.01 a 105.39 ± 1.66 a 5.12 ± 0.39 a 4.85 ± 0.19 a 33.67 ± 5.35 a 32.46 ± 1.27 a
S. commune SRB
F
7 days 15.76 ± 0.63 a 70.86 ± 2.52 b 2.60 ± 0.14 a 3.80 ± 0.08 a 0.28 ± 0.09 b 61.81 ± 4.78 a,c
14 days 32.42 ± 3.09 a 53.61 ± 2.32 b 7.40 ± 0.19 a 3.26 ± 0.96 a 9.69 ± 3.67 b 107.86 ± 12.8 a,c
21 days 30.18 ± 2.25 a 55.96 ± 1.31 b 7.62 ± 0.62 a 4.65 ± 0.31 a 57.10 ± 2.35 b 89.97 ± 12.81 a,c
28 days 69.69 ± 3.93 a 67.31 ± 1.03 b 3.25 ± 1.98 a 3.40 ± 0.09 a 4.36 ± 1.36 b 80.28 ± 3.21 a,c
M
7 days 18.92 ± 6.12 a 377.71 ± 14.85 b 7.78 ± 0.41 a 6.01 ± 0.07 a 20.89 ± 1.67 b 11.44 ± 0.84 a,d
14 days 71.55 ± 3.43 a 74.65 ± 1.74 b 3.17 ± 0.44 a 3.02 ± 0.10 a 9.55 ± 0.51 b 5.99 ± 0.20 a,d
21 days 69.13 ± 4.24 a 164.28 ± 2.52 b 2.30 ± 0.31 a 5.43 ± 0.53 a 5.61 ± 1.83 b 10.77 ± 1.05 a,d
28 days 51.41 ± 11.27 a 137.5 ± 5.87 b 2.14 ± 0.35 a 5.49 ± 0.23 a 0.90 ± 1.91 b 10.91 ± 0.46 a,d
Each value is expressed as mean ± SD. 1,2,3 Means with different letters (a–d) within two columns per test (DPPH, ABTS and FRAP) are significantly different (Tukey’s HSD, ANOVA, LSD, Friedman). Significant
differences between extracts were determined by Tukey’s HSD test and LSD post hoc test at p < 0.05. The differences are related to isolates (IT/SRB) and type of extracts (PSH/EtOH), and F/M (second letters).
Bold values stand for the most promising antioxidant activities.
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Table 2. Antiradical activity and total phenol content (TP) of submerged EtOH extracts of S. commune strains from Italy (IT) and Serbia (SRB). F—filtrate; M—mycelium; 7–28
days—Incubation time; GAE—gallic acid equivalents.
Extracts SOA (IC50) (µg/mL) OH (IC25) (µg/mL) NO (IC25) (µg/mL) TP (mgGAE/g.d.w.)
S. commune IT
F
7 days 526.68 ± 152.45 a 103.02 ± 12.23 a 614.02 ± 14.79 a 69.48 ± 1.00 a
14 days 652.14 ± 6.56 a 124.27 ± 7.00 a 965.43 ± 129.75 a 75.23 ± 1.04 a
21 days 90% 1 110.85 ± 2.31 a 707.05 ± 34.84 a 77.52 ± 0.97 a
28 days 90% 1 10.80 ± 0.54 a 1161.41 ± 48.90 a 68.70 ± 0.30 a
M
7 days 602.41 ± 0.01 a 20.20 ± 1.36 a 788.80 ± 36.36 a 53.49 ± 1.97 a
14 days 216.98 ± 45.84 a 228.36 ± 3.25 a 1182.78 ± 36.35 a 76.65 ± 1.30 a
21 days 634.14 ± 38.25 a 44.29 ± 4.20 a n.a. 2 42.74 ± 1.40 a
28 days 492.92 ± 125.11 a 84.74 ± 2.36 a n.a. 2 70.01 ± 0.65 a
S. commune SRB
F
7 days 635.74 ± 8.99 a 494.34 ± 59.08 a 1794.48 ± 13.21 a 84.60 ± 1.64 a
14 days 90% 1 257.92 ± 0.01 a <IC25 3 81.93 ± 0.81 a
21 days 90% 1 261.38 ± 0.01 a <IC25 3 78.27 ± 1.75 a
28 days 90% 1 89.69 ± 0.38 a <IC25 3 76.14 ± 1.42 a
M
7 days 161.60 ± 2.06 a 170.57 ± 0.35 a 737.12 ± 32.91 a 40.22 ± 0.82 a
14 days 253.14 ± 17.33 a 163.94 ± 19.22 a 145.88 ± 2.83 a 82.62 ± 0.99 a
21 days 429.60 ± 44.01 a 89.45 ± 0.01 a 785.34 ± 39.03 a 63.28 ± 1.28 a
28 days 218.01 ± 13.59 a 85.57 ± 0.12 a 112.19 ± 19.73 a 2.09 ± 0.06 a
Data are reported as mean ± SD of triplicates. Bold values highlight the best results. 1 90%, inhibitory concentration is higher than IC50; 2 n.a.—Non-active; 3 <IC25, the activity of analyzed samples is lower than
IC25. a In each column different letters, mean significant differences (Tukey’s HSD test at p < 0.05). The difference is related to isolate (IT/SRB) and type of samples (F/M).
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3.2.6. NO Assay
Among analyzed EtOH extracts, both isolates demonstrated moderate radical scav-
enging capacity, while some extracts were inactive or the activity of analyzed samples
waslower than IC25 (Table 2).
3.3. Determination of Antibacterial Activity
Studies on the MIC and MBC for EtOH extracts demonstrated that only two extracts
among all from SRB strain exhibited antibacterial activity, while IT strain was not active.
The F extract of SRB strain after 21 days of cultivation demonstrated the highest antimicro-
bial activity (MIC and MBC < 0.31%) against E. coli, B. cereus and S. aureus, while the lowest
was exhibited against P. aeruginosa (MIC and MBC 5%). F extract of SRB strain after 14 days
of incubation demonstrated antibacterial activity (MIC 0.62% and MBC 0.31%) only against
E. coli.
3.4. Total Phenol (TP) Content and Correlation Analysis
TP content is presented in Table 2. The amount of TP in both strains was high and
rather similar; nonetheless, SRB extracts showed a higher value (84.60 ± 1.64 mg GAE/g
d.w. for F and 82.62 ± 0.99 mg GAE/g d.w. for M, respectively). In addition, F extracts
of both strains demonstrated higher TP content compared to M. Correlation analysis
was performed to find out how AO of extracts is related to their TP content. A negative
correlation between antioxidant properties and TP content was noticed in the ABTS assay
of SRB extracts (r2 –0.79), while a close correlation (p < 0.05) in OH assay in both isolates
(r2 0.81 for IT and r2 0.71 for SRB) was obtained. In addition, a positive correlation was
detected between FRAP assay and TP content (r2 0.69 for IT).
3.5. Chemical Characterization of Extracts
3.5.1. FTIR Analysis
The spectra of all PSH samples investigated (Figure 2 (A–D) showed peaks characteris-
tic for the presence of predominantly polysaccharides molecules, small quantities of protein
and some aromatics. In all samples, the intensive sharp absorption at 1078–1080 cm−1 was
characteristic of the presence of β-glucan due to O-substituted glucose residues [36]. The
strong absorption at about 1050 cm−1 in each sample indicated that these polysaccharides
had pyranose rings [37]. An intensive absorption band with a maximum at 1640 cm−1
corresponded to the characteristic frequency of protein as well as to the bending vibration
O-H of associated water. This strong vibration was overlapped by specific absorption
of aromatics (C=C and C=O stretch vibrations) and indicated the presence of phenolic
compounds [38]. Frequencies at region 1410–1310 cm−1 corresponded to O-H groups of
phenolics, too. In the anomeric region (950–700 cm−1), the characteristic weak absorption
at 890 cm−1 in all samples corresponded to the presence of β-glycosidic linkages (C1-H
deformation mode) [39]. Furthermore, the additional weak frequency at 935 cm−1 in B and
C samples was also related to β-glycosidic bonds [40].
The FTIR spectrum of the EtOH extract (Figure S3) showed absorption bands charac-
teristic for the carbohydrate polymers as well as proteins and polyphenolic compounds [41].
The bands in the region 1310–1410 cm–1 correlate with the valence vibrations of the OH
groups of phenolic compounds. Among F samples of SRB extracts, the intensity of in-
dividual absorption bands was different. Namely, the intensity of bands in the region
1000–1200 cm−1 related to valence vibrations of CO and CC polysaccharide structures
is reduced compared to the intensities of other absorption peaks. This indicates a de-
crease in the proportion of carbohydrate polymers relative to other compounds present
in the mixture (e.g., phenols). The absence of the characteristic ester band in the region
1730–1740 cm−1 in all analyzed FTIR spectra indicates that the examined extracts do not
contain uronic acids as part of their structural characteristics.
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Figure 2. Fourier-transform infrared spectroscopy of polysaccharide samples isolated from S. commune.
Type of extracts examined: A—filtrate, 14 days, F IT; B—mycelium, 14 days, M IT: C—mycelium, 14 days,
M SRB; D—filtrate, 28 days, F SRB.
3.5.2. Monosaccharide Composition
The presence of a large amount of D-glucose with smaller amounts of D-galactose and
traces of D-mannose was confirmed in investigated hydrolysates by PC.
3.5.3. LC–MS/MS Analysis
In all examined PSH and EtOH, among 45 investigated phenolics, 4 compounds were
quantified using LC–MS/MS procedure (Table 3). Other phenolic compounds were above
the limit of detection but lower than the limit of quantification (Table S1). Three hydrox-
ybenzoic acids and one cyclohexane carboxylic acid were detected. p-Hydroxybenzoic
acid was detected in all investigated samples, while richer content was found in IT isolates
(64.92 µg/g in total). The most abundant compound was gallic acid found in SRB F extract
(75.77 µg/g). In comparison, EtOH extracts contained most of the analyzed phenolic acids,
whereas F extracts showed higher phenolic content than M (167.55 µg/g in total).
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Table 3. Determined concentrations of selected phenolic compounds using LC–MS/MS technique in examined polysaccha-
ride and ethanolic extracts (µg/g.d.w.).
Extracts
Class of Analyzed Compounds
Hydroxybenzoic Acids Cyclohexane Carboxylic Acid
p-Hydroxybenzoic Acid Protocatechuic Acid Gallic Acid Quinic Acid
PSH
IT F 7 5.50 3.17 <12.2 * <3.05 *
IT M 7 1.87 <1.525 * <12.2 * <3.05 *
IT M 14 8.28 <1.525 * <12.2 * <3.05 *
SRB F 7 <1.525 * <1.525 * <12.2 * 4.29
EtOH
IT F 14 3.81 <1.525 * <12.2 * 13.24
IT F 21 9.51 <1.525 * <12.2 * <3.05 *
IT M 14 4.10 <1.525 * <12.2 * 8.57
IT M 21 9.66 <1.525 * <12.2 * <3.05 *
IT M 28 22.19 5.41 <12.2 * 4.82
SRB F 7 12.14 <1.525 * <12.2 * 15.51
SRB F 14 3.77 <1.525 * 75.77 <3.05 *
SRB F 21 11.25 1.90 <12.2 * <3.05 *
SRB F 28 7.69 <1.525 * <12.2 * <3.05 *
SRB M 7 5.93 <1.525 * <12.2 * 19.52
SRB M 14 5.94 <1.525 * <12.2 * 20.06
SRB M 21 6.52 <1.525 * <12.2 * 5.49
Bold number: the amount of quantified phenolic compounds in examined extracts. * Number: detected compound—Peak observed,
concentration is lower than the LoQ (limit of quantification) but higher than the LoD (limit of detection). PSH—polysaccharide extracts;
EtOH—ethanolic extracts; IT—isolate from Italy; SRB—isolate from Serbia; F—filtrate; M—mycelium; 7, 14, 21, 28—days of incubation.
4. Discussion
Inhibition of AChE enzyme was determined and compared for PSH and EtOH extracts
of both investigated strains of S. commune (Figure 1). All PSH extracts, both M and F,
exhibited significantly strong activity, hence expressed as IC90, which is comparable to the
activity of a commercially approved AD drug donepezil (87.92%). Though some subtle
distinction exists, the FTIR spectrum of PSH extracts (Figure 2) indicates that there are
no significant differences in the composition of the F and M, owing to the mixture of
polysaccharide fraction, probably schizophyllan structure [42], which is further expressed
by their very similar AChE inhibitory activity.
Among EtOH extracts, stronger AChEI was observed for IT F extracts after 14 days
of cultivation, while among PSH extracts, SRB M expressedgreater inhibition potential
after 28 days of incubation. Furthermore, the incubation period did not show a statistically
significant difference in PSH extracts (ANOVA, p < 0.05), while among EtOH incubation
period had a greater impact (p = 0.04)on the AChEI activity, with 14 and 28 days being the
highest (Figure 1B).This can be explained by the highest production of secondary metabo-
lites, including phenolics in submerged cultivation in the stationary phase of cultivation
when nutritive components are limited LC-MS/MS analysis (Table 3) revealed that within
strongest EtOH extracts beside p-hydroxybenzoic acid, a high amount of quinic acid were
found. Though in a previous study, quinic acid did not inhibit the AChE enzyme [43], it
was shown that p-hydroxybenzoic acid exhibited lower inhibitory activity compared to
2-hydroxybenzoic acid [44]. The concentration of esculetin, a derivative of coumarin, in
all examined submerged extracts of S. commune was higher than the limit of detection,
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while in Coprinus comatus, its presence in both mycelia and filtrate was recorded in a higher
amount using HPLC-MS/MS procedure [45]. Ali et al. [46] demonstrated strong AChEI
activity of this compound isolated from plants, and its AO was reported [44]. On the other
hand, polysaccharides originating from mushrooms could be significant in AD therapy
since in vivo experiments indicate that they might improve learning and memory [47].
Furthermore, the FTIR spectrum of PSH and EtOH extracts (Figure 2 and Figure S3) showed
the presence of predominantly polysaccharide molecules next to proteins and phenolic
compounds. Shizophyllan, β-1,3 beta-glucan with β-1,6 branching, a potent polysaccharide
found in S. commune, may play an important role since PSH extracts exhibited high AChE
inhibitory activity, opposite to PSH samples for Trametes versicolor, extracted after the same
procedure, where activity was not detected [10]. In addition, EtOH samples demonstrated
lower AChE inhibitory activity (44.35%) [10], compared to our results (Figure 1), while
Abdullah et al. [48] recorded weak AChEI activity of hot water extracts of S. commune
(IC50 0.320 ± 0.070 mg/mL).
AO of PSH and EtOH extracts was evaluated in vitro using standard antioxidant
assays (Tables 1 and 2). Based on Table 1, there are statistically significant differences
(ANOVA and Friedman, p < 0.05) among PSH and EtOH samples from SRB in DPPH and
FRAP assays. EtOH samples from OH assay stands out since in NO and SOA tests, except
F extracts, much lower antiradical activity was recorded (Table 2). The highest activity of F
extracts (IT, 28 days) showed significant value (IC25 10.80 ± 0.54 µg/mL) while among SRB
samples, the activity of F and M (IC25 89.69 ± 0.38 µg/mL andIC25 85.57 ± 0.12 µg/mL,
respectively) for the same incubation period was almost eight times lower.
Results of OH assays for EtOH extracts are comparable with TP content since a
high positive correlation was obtained (r2 0.81 for IT and r2 0.71 for SRB). Moreover,
these results suggest the potential use of this mushroom for the prevention of oxidative
stress since OH is physiologically active and toxic [28]. DPPH assay did not show a
statistically significant difference in correlation with TP content, although previous data
from submerged methanol samples of Coprinus species demonstrated a positive correlation,
which may be due to the application of different solvents [49].EtOH and MeOH extracts of
S. commune showed three times lower anti-DPPH activity (IC50 153.1 ± 0.02µg/mL) [48],
while EtOH extract of the same species from India demonstrated two times higher RSC
IC50 18.56 µg/mL [50], compared to the strongest reported herein for EtOH extracts (IC50
49.34 ± 0.65 µg/mL). EtOH extracts from submerged fermented mycelium (10 days)
demonstrated stronger scavenging capacity as reported by Tripathi and Tiwary with
IC50 31.40 ± 0.05 µg/mL [51]. In other studies, lower scavenging capacity and reducing
the effect of fruiting body extracts were recorded as well, while TP content varied from
significantly reduced value (1.72 ± 0.05 mg GAE/g d.w. and 2.99 ± 0.04 mg GAE/g d.w.)
to twice the lower value (41.07 ± 0.60 mg GAE/g d.w.) [52–54]. Nevertheless, submerged
extracts of S. commune from Thailand showed higher DPPH activity (inhibition of DPPH
ranged from 34.29 to 81.00%) with fermentation broth being twice as active [55], which
is in accordance with our study and refers to the production of secondary metabolites
during submerged cultivation. Given what has been said, a higher amount of TPcontent in
F extracts (Table 2) quantified by LC–MS/MS (Table 3) indicates that fungal cells represent
small bio-factories since various classes of metabolites can be produced during the same
procedure of submerged cultivation. In comparison, PSH and EtOH extracts of T. versicolor
exhibited RSC activity 50 times lower [10], which impliesthat besides phenolic compounds,
primary metabolites, including polysaccharides, may play a role in AO.
LC–MS/MS procedure of extracts from the fruiting body of this mushroom species
detected only protocatechuic and hydroxybenzoic acids in higher amounts [56], while
lower amounts of various phenolic compounds were detected (Table S1). This quanti-
tative and qualitative variability is expected considering the different origins of fungal
growth (mycelia, extracellular media) during submerged cultivation can produce differ-
ent classes and concentrations of metabolites. According to growth curves, SRB strain
(Figures S1 and S2) has rapid growth and reached the critical point of entry in secondary
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metabolism much earlier (14 days) than IT strain, when a very high concentration of gallic
acid was observed. This can explain high DPPH and FRAP activities for SRB strain as well [57].
IT strain expressed critical points between 21 and 28 days (Figure S1) when different phenolic
compounds were detected. All confirmed phenolic compounds (Table 3) are proven antioxi-
dants [58,59], whereas LC–MS/MS analysis demonstrated higher phenolic content in EtOH
extracts. Hence, the observed abilities of EtOH extracts may be explained by the presence
of secondary metabolites, while primary metabolites may be responsible for high RSC
activity among PSH extracts.
Antibacterial activity was very low as only two extracts showed activity. In a previous
study, methanolic extract of culture filtrate incubated in submerged conditions for 10 days
was active against two Gram-positive bacteria (S. aureus and B. subtilis) [51], which is in
accordance with results from this study, since only F extracts of SRB strain showed moderate
antibacterial activity.LC–MS/MS analysis and literature data both imply that gallic acid,
protocatechuic acid and esculetin may be responsible for antibacterial activity since these
compounds can inhibit the growth of E. coli [59–62]. Nonetheless, extracellular pigment
melanin from S. commune was active against E. coli as well [63], suggesting a possible
synergy effect.
Findings from this study suggest that different compounds, both primary and sec-
ondary, could be responsible for inhibition of AChE enzyme as well as for detected AO
and antibacterial activities that strongly point out to a likelihood of synergistic activity of
compounds in the extracts [16]. Based on observed AChEI activity, different geograph-
ical locations (strain origin—IT, SRB) from which the fungal strains were collected may
affect the activity and the production of various metabolites probably due to different
environmental factors that contribute to the biochemical patterns of the specific genotype
(strain).
5. Conclusions
To the best of our knowledge, this is the first report describing the AChE inhibitory
activity of PSH extracts of submerged extracts of S. commune. Most of the analyzed sub-
merged samples exhibited AO, which is in direct relation to the characteristics of strain’s
growth as it can point to the moment of entry in secondary metabolism, while in AChEIac-
tivity, PSH extracts demonstrated remarkable results and represent first data for this species.
Taken all together, PSH extracts obtained significant AO within samples incubated for
7 days, opposite to EtOH extracts where a 14- and 21-day cultivation period stood out,
which was in accordance with LC–MS/MS phenolic analysis. Differences in activities
between two isolates and different types of extracts, together with variations of phenolics
content, indicate the important role of both genetic and environmental factors in metabolite
production, as well as possible synergistic effect of primary and secondary metabolites.
This study introduced S. commune as a potential natural antioxidant producer and indi-
cated that the submerged fermentation might serve as an effective alternative method for
producing bioactive agents, e.g., pharmaceuticals and nutraceuticals. In summary, this
ubiquitous mushroom species should be considered as a valuable alternative source for
future palliative therapy of AD.
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Serbia (SRB); Figure S3: Fourier-transform infrared spectroscopy of ethanol samples of S. commune
isolates from Serbia (SRB) and Italy (IT); Table S1: Determined concentrations of phenolic compounds
using LC–MS/MS technique isexamined polysaccharide and ethanolic extracts (µg/g).
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